Persistence and evolution of SARS-CoV-2 in an immunocompromised host
B Choi, MC Choudhary, J Regan… - … England Journal of …, 2020 - Mass Medical Soc
New England Journal of Medicine, 2020•Mass Medical Soc
SARS-CoV-2 in an Immunocompromised Host This letter describes an
immunocompromised patient who had persistent infection with SARS-CoV-2 over a period
of months, despite several courses of remdesivir. Phylogenetic analysis showed accelerated
viral evolution.
immunocompromised patient who had persistent infection with SARS-CoV-2 over a period
of months, despite several courses of remdesivir. Phylogenetic analysis showed accelerated
viral evolution.
SARS-CoV-2 in an Immunocompromised Host
This letter describes an immunocompromised patient who had persistent infection with SARS-CoV-2 over a period of months, despite several courses of remdesivir. Phylogenetic analysis showed accelerated viral evolution.
The New England Journal Of Medicine